1 Medical Oncology/Institute of Cancer Sciences, The Christie NHS Foundation Trust/University of Manchester, Manchester, United Kingdom.
2 Department of Liver and Gastrointestinal Diseases, Biodonostia Health Research Institute - Donostia University Hospital, University of the Basque Country (UPV/EHU), San Sebastian, Spain.
3 Institute of Pathology, University of Regensburg, Regensburg, Germany.
4 BCLC Group, Liver Unit, Hospital Clínic Barcelona, Barcelona, Spain.
5 National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Carlos III National Health Institute, Madrid, Spain.
6 Department of Medical Oncology Hospital, Universitario 12 de Octubre, Madrid, Spain.
7 Section of Gastroenterology and the Norwegian PSC Research Center, Department of Transplantation Medicine, Oslo University Hospital, Oslo, Norway.
8 Molecular Medicine, University of Padua, Padua, Italy.
9 Experimental Hepatology and Drug Targeting (HEVEPHARM) Group, University of Salamanca, IBSAL, Salamanca, Spain.
10 Department of Medicine II, Saarland University Medical Centre, Saarland University, Homburg, Germany.
11 Laboratory of Metabolic Liver Diseases, Centre for Preclinical Research, Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland.
12 Department of General, Transplant and Liver Surgery, Medical University of Warsaw, Warsaw, Poland.
13 Gastroenterology, Sapienza University of Rome, Rome, Italy.
14 Medical Oncology, The University of Glasgow, Glasgow, United Kingdom.
15 IKERBASQUE, Basque Foundation for Science, Bilbao, Spain.